{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:48:48Z","timestamp":1791265728371,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cyto.2025.157016","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:11:04Z","timestamp":1755695464000},"page":"157016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The role of CXCL10 in cartilage development and diseases"],"prefix":"10.1016","volume":"195","author":[{"given":"Xi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.157016_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2025.157016_bb0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","article-title":"Biochemical characterization of a gamma interferoninducible cytokine (IP-10)","volume":"166","author":"Luster","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0015","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2009-01-199497","article-title":"Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6","volume":"114","author":"Dyer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.157016_bb0020","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2353\/ajpath.2010.081059","article-title":"CXCR3\/ligands are significantly involved in the tumorigenesis of basal cell carcinomas","volume":"176","author":"Lo","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2025.157016_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2016.02.007","article-title":"Hypoxia\/ischemia promotes CXCL10 expression in cardiac microvascular endothelial cells by NFkB activation","volume":"81","author":"Xia","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2025.157016_bb0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0035","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41413-022-00239-4","article-title":"The role of TGF-beta3 in cartilage development and osteoarthritis","volume":"11","author":"Du","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0363546518756087","article-title":"Anterior cruciate ligament transection-induced cellular and extracellular events in menisci: implications for osteoarthritis","volume":"46","author":"Xie","year":"2018","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41368-022-00165-5","article-title":"Microenvironmental stiffness mediates cytoskeleton re-organization in chondrocytes through laminin-FAK mechanotransduction","volume":"14","author":"Zhou","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.cyto.2025.157016_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","article-title":"Pro-inflammatory cytokines: the link between obesity and osteoarthritis","volume":"44","author":"Wang","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110605","article-title":"IL-10 enhances cell-to-cell communication in chondrocytes via STAT3 signaling pathway","volume":"105","author":"Guo","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cyto.2025.157016_bb0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1302\/2046-3758.108.BJR-2021-0086","article-title":"The role of TGF-\u03b22 in cartilage development and diseases","volume":"10","author":"Duan","year":"2021","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0070","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/jcmm.17174","article-title":"The role of fibroblast growth factor 8 in cartilage development and disease","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167921","article-title":"CXCL8 and GZMB genes promote cartilaginous and synovial lesion formation via NF-\u03baB and MAPK signaling pathways in Kaschin-Beck disease","volume":"1871","author":"Cai","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0085","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/annrheumdis-2016-210426","article-title":"CCL2\/CCR2, but not CCL5\/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis","volume":"76","author":"Raghu","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0090","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/rheumatology\/keab763","article-title":"CXCL13 predicts long-term radiographic status in early rheumatoid arthritis","volume":"61","author":"Greisen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2025.157016_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-018-1611-2","article-title":"Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis","volume":"20","author":"Armas-Gonz\u00e1lez","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cytogfr.2020.05.007","article-title":"The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis","volume":"55","author":"Van Raemdonck","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.joca.2020.10.010","article-title":"The role of stromal cell-derived factor 1 on cartilage development and disease","volume":"29","author":"Li","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2025.157016_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179208","article-title":"Cytokines and chemokines involved in osteoarthritis pathogenesis","volume":"22","author":"Molnar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157016_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133435","article-title":"Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets","volume":"14","author":"Barbarroja","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jor.23735","article-title":"CXCL10 is upregulated in synovium and cartilage following articular fracture","volume":"36","author":"Furman","year":"2018","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0130","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.23372","article-title":"Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis","volume":"58","author":"Kwak","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-017-1353-6","article-title":"Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis","volume":"19","author":"Lee","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0140","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.84.9.2868","article-title":"Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells","volume":"84","author":"Luster","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157016_bb0145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/j.gastro.2007.12.044","article-title":"Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers","volume":"134","author":"Deng","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2025.157016_bb0150","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.179.4.1373","article-title":"Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes","volume":"179","author":"Gattass","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0155","article-title":"Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation","volume":"7","author":"Doi","year":"1987","journal-title":"Moles Cell Bid."},{"key":"10.1016\/j.cyto.2025.157016_bb0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2025.157016_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","article-title":"The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily","volume":"8","author":"Neville","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0175","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.it.2018.06.003","article-title":"Peripheral tissue chemokines: homeostatic control of immune surveillance T cells","volume":"39","author":"McCully","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2025.157016_bb0190","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102718118","article-title":"EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner","volume":"118","author":"Bugide","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157016_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2018.01.029","article-title":"The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model","volume":"419","author":"Mirzaei","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2025.157016_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.157016_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.42.091901.115838","article-title":"Structure, function, and inhibition of chemokines","volume":"42","author":"Fernandez","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cyto.2025.157016_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fasebj.9.1.7821760","article-title":"Three-dimensional structures of alpha and beta chemokines","volume":"9","author":"Clore","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.cyto.2025.157016_bb0215","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1074\/jbc.M114.627786","article-title":"Structure-function analysis of CCL28 in the development of post-viral asthma","volume":"290","author":"Thomas","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/152581601750098417","article-title":"Human recombinant interferon-inducible protein-10: intact disulfide bridges are not required for inhibition of hematopoietic progenitors and chemotaxis of T lymphocytes and monocytes","volume":"10","author":"Crow","year":"2001","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0225","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbrc.2005.10.062","article-title":"Investigation of CC and CXC chemokine quaternary state mutants","volume":"338","author":"Jin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2025.157016_bb0230","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1073\/pnas.0334864100","article-title":"Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines","volume":"100","author":"Proudfoot","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157016_bb0235","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0969-2126(03)00070-4","article-title":"Crystal structures of oligomeric forms of the IP-10\/CXCL10 chemokine","volume":"11","author":"Swaminathan","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.cyto.2025.157016_bb0240","doi-asserted-by":"crossref","first-page":"17066","DOI":"10.1074\/jbc.M212077200","article-title":"CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)","volume":"278","author":"Campanella","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0245","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj3130633","article-title":"Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity","volume":"313","author":"Beall","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2025.157016_bb0250","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","article-title":"Chemokine: receptor structure, interactions, and antagonism","volume":"25","author":"Allen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0255","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ni.f.207","article-title":"How chemokines invite leukocytes to dance","volume":"9","author":"Thelen","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0260","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm1196-1174","article-title":"Chemokine receptors: gateways to inflammation and infection","volume":"2","author":"Premack","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0265","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.bi.60.070191.002025","article-title":"Structure and function of signal-transducing GTP-binding proteins","volume":"60","author":"Kaziro","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cyto.2025.157016_bb0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0167-4889(00)00088-4","article-title":"Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins","volume":"1498","author":"Sallese","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2025.157016_bb0280","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/jbc.273.2.669","article-title":"The many faces of G protein signaling","volume":"273","author":"Hamm","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0898-6568(99)00008-X","article-title":"Intracellular signalling pathways induced by chemokines in natural killer cells","volume":"11","author":"Maghazachi","year":"1999","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cyto.2025.157016_bb0290","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1021\/bi9811415","article-title":"Interleukin-8 receptors R1 and R2 activate mitogenactivated protein kinases and induce cfos, independent of Ras and Raf-1 in Chinese hamster ovary cells","volume":"37","author":"Shyamala","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.cyto.2025.157016_bb0295","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1126\/science.8134838","article-title":"High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR","volume":"263","author":"Lodi","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cyto.2025.157016_bb0300","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0305","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization","volume":"28","author":"Loetscher","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0310","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157016_bb0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.cyto.2025.157016_bb0325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0335","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1189\/jlb.5A0116-025R","article-title":"Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects","volume":"100","author":"Pandya","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2025.157016_bb0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"issue":"2015","key":"10.1016\/j.cyto.2025.157016_bb0345","first-page":"2961","article-title":"Pillars article: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000. 100: 655-669","volume":"194","author":"Szabo","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0350","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.177.9.5890","article-title":"T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity","volume":"177","author":"Taqueti","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0355","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells","volume":"81","author":"Garc\u00eda-L\u00f3pez","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cyto.2025.157016_bb0360","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.194.9.1375","article-title":"Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment","volume":"194","author":"Janatpour","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0365","first-page":"287","article-title":"CXCR3, a double-edged sword in tumor progression and angiogenesis","volume":"1836","author":"Billottet","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2025.157016_bb0370","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0375","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping","volume":"173","author":"Ehlert","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0380","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2567.2010.03384.x","article-title":"Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes","volume":"132","author":"Korniejewska","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2025.157016_bb0385","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.167.2.623","article-title":"Cutting edge: IFN-inducible ELR- CXC 7chemokines display defensin-like antimicrobial activity","volume":"167","author":"Cole","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2009.01.003","article-title":"CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling","volume":"9","author":"Schulthess","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.cyto.2025.157016_bb0395","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.4049\/jimmunol.167.10.5887","article-title":"Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes","volume":"167","author":"Kawai","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0400","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/eji.200737898","article-title":"TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells","volume":"38","author":"Eskan","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0405","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.cellsig.2013.06.010","article-title":"Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses","volume":"25","author":"Abdulkhalek","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cyto.2025.157016_bb0410","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3724\/abbs.2023125","article-title":"Calycosin attenuates the inflammatory damage of microglia induced by oxygen and glucose deprivation through the HMGB1\/TLR4\/NF-\u03baB signaling pathway","volume":"55","author":"Li","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cyto.2025.157016_bb0415","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2010-01-266072","article-title":"A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils","volume":"116","author":"Massena","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.157016_bb0420","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajpath.2016.10.009","article-title":"Critical role of the CXCL10\/C-X-C chemokine receptor 3 Axis in promoting leukocyte recruitment and neuronal injury during traumatic optic neuropathy induced by optic nerve crush","volume":"187","author":"Ha","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2025.157016_bb0425","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.02-0908fje","article-title":"Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop","volume":"18","author":"Campbell","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.cyto.2025.157016_bb0430","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection","volume":"193","author":"Hancock","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0435","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3: activation of Ras\/ERK, Src, and phosphatidylinositol 3-kinase\/Akt controls cell migration and proliferation in human vascular pericytes","volume":"276","author":"Bonacchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0440","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.freeradbiomed.2023.01.002","article-title":"Neurotoxic A1 astrocytes promote neuronal ferroptosis via CXCL10\/CXCR3 axis in epilepsy","volume":"195","author":"Liang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0445","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1460-9568.2006.04631.x","article-title":"CXCL10-induced cell death in neurons: role of calcium dysregulation","volume":"23","author":"Sui","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cyto.2025.157016_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.281","article-title":"Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma","volume":"6","author":"Ha","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0455","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.26069","article-title":"Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes","volume":"57","author":"Sahin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2025.157016_bb0460","doi-asserted-by":"crossref","first-page":"38675","DOI":"10.1074\/jbc.M306494200","article-title":"Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation","volume":"278","author":"Jakobi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0465","first-page":"1489","article-title":"CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival","volume":"91","author":"Giuliani","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2025.157016_bb0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/ASO.2006.03.038","article-title":"Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells","volume":"13","author":"Feldman","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cyto.2025.157016_bb0475","doi-asserted-by":"crossref","first-page":"24286","DOI":"10.1074\/jbc.271.39.24286","article-title":"Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response","volume":"271","author":"Wang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0480","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcsm.12584","article-title":"Age-related decline of interferon-gamma responses in macrophage impairs satellite cell proliferation and regeneration","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157016_bb0485","first-page":"L909","article-title":"CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation","volume":"290","author":"Aksoy","year":"2006","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cyto.2025.157016_bb0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.02.116","article-title":"MAP kinase regulation of IP10\/CXCL10 chemokine gene expression in microglial cells","volume":"1086","author":"Shen","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0495","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2008.04.029","article-title":"Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation","volume":"199","author":"Maru","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0500","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2012.02.036","article-title":"Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation","volume":"419","author":"Watts","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2025.157016_bb0505","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1681\/ASN.2008040394","article-title":"Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression","volume":"19","author":"Datta","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cyto.2025.157016_bb0510","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1158\/0008-5472.CAN-05-4345","article-title":"Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer","volume":"66","author":"Datta","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012700","article-title":"CXCL10 can inhibit endothelial cell proliferation independently of CXCR3","volume":"5","author":"Campanella","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2025.157016_bb0520","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0525","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines: the regulatory link between inflammation and angiogenesis","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0530","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)65699-4","article-title":"Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing","volume":"153","author":"Engelhardt","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2025.157016_bb0535","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity","volume":"107","author":"Romagnani","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2025.157016_bb0540","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.184.3.981","article-title":"Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases","volume":"184","author":"Arenberg","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0545","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1073\/pnas.93.24.13791","article-title":"Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo","volume":"93","author":"Sgadari","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157016_bb0550","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.10292","article-title":"Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts","volume":"99","author":"Feldman","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2025.157016_bb0555","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.7150\/ijbs.110133","article-title":"Fibroblast growth factor 19 disrupts cartilage development via the FGFR4\/\u03b2-catenin axis","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2025.157016_bb0560","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrendo.2015.165","article-title":"Short and tall stature: a new paradigm emerges","volume":"11","author":"Baron","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cyto.2025.157016_bb0565","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1534-5807(03)00095-9","article-title":"Patterning systems\u2013from one end of the limb to the other","volume":"4","author":"Tickle","year":"2003","journal-title":"Dev. Cell"},{"issue":"Suppl","key":"10.1016\/j.cyto.2025.157016_bb0570","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/01.blo.0000143805.64755.4f","article-title":"Chemokines in cartilage degradation","volume":"427","author":"Borz\u00ec","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0575","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/ten.a.2007.0121","article-title":"Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage","volume":"14","author":"Cristino","year":"2008","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.cyto.2025.157016_bb0580","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygeno.2006.02.013","article-title":"Activation of genes for growth factor and cytokine pathways late in chondrogenic differentiation of ATDC5 cells","volume":"88","author":"Osawa","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.cyto.2025.157016_bb0585","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1074\/jbc.RA119.007356","article-title":"The antiviral protein viperin regulates chondrogenic differentiation via CXCL10 protein secretion","volume":"294","author":"Steinbusch","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157016_bb0590","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1039\/D4CS00450G","article-title":"Intrinsic immunomodulatory hydrogels for chronic inflammation","volume":"54","author":"Qian","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0595","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.biomaterials.2004.03.005","article-title":"A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells","volume":"26","author":"Li","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.cyto.2025.157016_bb0600","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/art.24786","article-title":"Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro","volume":"60","author":"Lee","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0605","doi-asserted-by":"crossref","DOI":"10.1097\/01.blo.0000131638.81519.de","article-title":"Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis","volume":"423","author":"Buckwalter","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0610","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.joca.2010.08.003","article-title":"Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells","volume":"18","author":"Endres","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2025.157016_bb0615","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","article-title":"Innate immunity and rheumatoid arthritis","volume":"36","author":"Gierut","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.cyto.2025.157016_bb0620","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2016.05.009","article-title":"The joint synovium: A critical determinant of articular cartilage fate in inflammatory joint diseases","volume":"62","author":"Bhattaram","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cyto.2025.157016_bb0625","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/rheumatology\/keg447","article-title":"T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion","volume":"43","author":"O\u2019Gradaigh","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2025.157016_bb0630","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar616","article-title":"A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis","volume":"5","author":"Hanaoka","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0635","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1186\/ar783","article-title":"High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis","volume":"5","author":"Ruschpler","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0640","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93599-6","article-title":"A myostatin-CCL20-CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis","volume":"11","author":"Fennen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2025.157016_bb0645","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0650","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B","article-title":"Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis","volume":"43","author":"Wedderburn","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0655","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199301283280408","article-title":"New concepts about the mast cell","volume":"328","author":"Galli","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0660","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-020-02349-y","article-title":"T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3+Th2 phenotype","volume":"22","author":"Aldridge","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2025.157016_bb0670","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0675","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/38.3.202","article-title":"Cytokine production by synovial T cells in rheumatoid arthritis","volume":"38","author":"Steiner","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2025.157016_bb0680","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","article-title":"The type I IFN signature as a biomarker of preclinical rheumatoid arthritis","volume":"72","author":"L\u00fcbbers","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106356","article-title":"Synergistic induction of CCL5, CXCL9 and CXCL10 by IFN-\u03b3 and NLRs ligands on human fibroblast-like synoviocytes-A potential immunopathological mechanism for joint inflammation in rheumatoid arthritis","volume":"82","author":"Yu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2025.157016_bb0690","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13075-017-1224-1","article-title":"Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker","volume":"19","author":"Pandya","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0695","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/annrheumdis-2014-206993","article-title":"The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?","volume":"74","author":"Raza","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0700","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X16654476","article-title":"Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications","volume":"8","author":"Espinoza","year":"2016","journal-title":"Ther. Adv. Musculoskelet Dis."},{"issue":"6","key":"10.1016\/j.cyto.2025.157016_bb0705","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0710","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","article-title":"The interaction between CXCL10 and cytokines in chronic inflammatory arthritis","volume":"12","author":"Lee","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0715","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ni1576","article-title":"TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes","volume":"9","author":"Yarilina","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0720","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard.2011.150284","article-title":"The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon","volume":"71","author":"Rosengren","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157016_bb0725","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","article-title":"Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration","volume":"105","author":"Kwak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.157016_bb0730","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar3385","article-title":"Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0735","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-016-0995-0","article-title":"Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study","volume":"18","author":"Han","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0740","first-page":"S152","article-title":"Side effects of anti-TNF therapy: current knowledge","volume":"20","author":"Antoni","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0745","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/03009742.2011.623137","article-title":"Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5","volume":"41","author":"Yoshida","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0750","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41413-021-00173-x","article-title":"Runx1 protects against the pathological progression of osteoarthritis","volume":"9","author":"Zhou","year":"2021","journal-title":"Bone Res."},{"key":"10.1016\/j.cyto.2025.157016_bb0755","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/abbs\/gmab021","article-title":"Lipid metabolism in cartilage and its diseases: a concise review of the research progress","volume":"53","author":"Yang","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cyto.2025.157016_bb0760","article-title":"TGF-beta2 enhances nanoscale cortex stiffness via condensation of cytoskeleton-focal adhesion plaque","author":"Duan","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.cyto.2025.157016_bb0765","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0770","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3724\/abbs.2023086","article-title":"The role of mechano growth factor in chondrocytes and cartilage defects: a concise review","volume":"55","author":"Liu","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cyto.2025.157016_bb0775","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500186R","article-title":"Fibroblast growth factor 8 (FGF8) induces mitochondrial remodeling in chondrocytes via ERK\/AMPK signaling pathway","volume":"39","author":"Huang","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.cyto.2025.157016_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118804","article-title":"Role of the fibroblast growth factor 19 in the skeletal system","volume":"265","author":"Chen","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2025.157016_bb0785","doi-asserted-by":"crossref","DOI":"10.3724\/abbs.2025075","article-title":"FGF8 promotes lipid droplet accumulation via the FGFR1\/p-p38 axis in chondrocytes","author":"Huang","year":"2025","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cyto.2025.157016_bb0790","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.joca.2013.04.002","article-title":"An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid","volume":"21","author":"Beekhuizen","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2025.157016_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101249","article-title":"The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis","volume":"66","author":"Zheng","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0800","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0805","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/jcm8101631","article-title":"Divergent mononuclear Cell participation and cytokine release profiles define hip and knee osteoarthritis","volume":"8","author":"Grieshaber-Bouyer","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0810","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/BOR.0b013e32833b4682","article-title":"The evolving role of obesity in knee osteoarthritis","volume":"22","author":"Sowers","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0815","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-109-1-18","article-title":"Obesity and knee osteoarthritis","volume":"109","author":"Felson","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cyto.2025.157016_bb0820","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.joca.2015.01.015","article-title":"Using diet-induced obesity to understand a metabolic subtype of osteoarthritis in rats","volume":"23","author":"Collins","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2025.157016_bb0825","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00264-010-1100-y","article-title":"Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients","volume":"35","author":"Hu","year":"2011","journal-title":"Int. Orthop."},{"key":"10.1016\/j.cyto.2025.157016_bb0830","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-8587(14)70007-5","article-title":"The bone-fat interface: basic and clinical implications of marrow adiposity","volume":"3","author":"Devlin","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cyto.2025.157016_bb0835","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1463-1326.2008.00974.x","article-title":"Diet-induced adiposity alters the serum profile of inflammation in C57BL\/6N mice as measured by antibody array","volume":"11","author":"Fenton","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cyto.2025.157016_bb0840","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00264-013-2192-y","article-title":"Relationship of plasma and synovial fluid vascular endothelial growth factor with radiographic severity in primary knee osteoarthritis","volume":"38","author":"Saetan","year":"2014","journal-title":"Int. Orthop."},{"key":"10.1016\/j.cyto.2025.157016_bb0845","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/rheumatology\/keab679","article-title":"New developments in osteoarthritis pharmacological therapies","volume":"60","author":"Ghouri","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2025.157016_bb0850","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-016-1083-1","article-title":"Suppression of the inflammatory response by disease-inducible interleukin-10 gene therapy in a three-dimensional micromass model of the human synovial membrane","volume":"18","author":"Broeren","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0855","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2025.157016_bb0860","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/hum.2020.319","article-title":"Adeno-associated virus-mediated overexpression of Interleukin-10 affects the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells","volume":"32","author":"Cameron","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0865","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0870","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.joca.2019.10.010","article-title":"Osteoarthritis-associated basic calcium phosphate crystals alter immune cell metabolism and promote M1 macrophage polarization","volume":"28","author":"Mahon","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2025.157016_bb0875","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0880","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","article-title":"Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis","volume":"160","author":"Reich","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0885","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3899\/jrheum.150466","article-title":"Clinical and demographic characteristics of Erosion-free and Erosion-present status in psoriatic arthritis in a cohort study","volume":"43","author":"Touma","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0890","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2025.157016_bb0895","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157016_bb0900","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13075-016-1196-6","article-title":"Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis","volume":"18","author":"Muntyanu","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2025.157016_bb0905","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/jid.2014.414","article-title":"Gene expression differences between psoriasis patients with and without inflammatory arthritis","volume":"135","author":"Pollock","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2025.157016_bb0910","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11926-014-0414-y","article-title":"The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment","volume":"16","author":"Frleta","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cyto.2025.157016_bb0915","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","article-title":"Role of IL-17 in psoriasis and psoriatic arthritis","volume":"44","author":"Raychaudhuri","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cyto.2025.157016_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102846","article-title":"CCR6-CCL20 axis as a therapeutic target for autoimmune diseases","volume":"20","author":"Meitei","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2025.157016_bb0925","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1172\/JCI37378","article-title":"Ccr6 is required for IL-23-induced psoriasis-like inflammation in mice","volume":"119","author":"Hedrick","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2025.157016_bb0930","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/andr.13571","article-title":"The CXCL10\/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K\/AKT pathway","volume":"12","author":"Yue","year":"2024","journal-title":"Andrology"},{"key":"10.1016\/j.cyto.2025.157016_bb0935","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.69.5.691","article-title":"Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37)","volume":"69","author":"Yang","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2025.157016_bb0940","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70048","article-title":"Gut microbiota-derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation","author":"Wang","year":"2025","journal-title":"iMeta"},{"key":"10.1016\/j.cyto.2025.157016_bb0945","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/eji.200324136","article-title":"Microbial Toll-like receptor ligands differentially regulate CXCL10\/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis","volume":"33","author":"Proost","year":"2003","journal-title":"Eur. J. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T21:43:42Z","timestamp":1758663822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":189,"alternative-id":["S1043466625001632"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of CXCL10 in cartilage development and diseases","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157016"}}